KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Cash & Current Investments (2016 - 2025)

Pfizer (PFE) has disclosed Cash & Current Investments for 17 consecutive years, with $15.0 billion as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Current Investments rose 1272.16% to $15.0 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $15.0 billion, a 1272.16% increase, with the full-year FY2024 number at $20.5 billion, up 61.36% from a year prior.
  • Cash & Current Investments was $15.0 billion for Q3 2025 at Pfizer, up from $1.6 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $31.1 billion in Q4 2021 to a low of $416.0 million in Q4 2022.
  • A 5-year average of $6.5 billion and a median of $2.4 billion in 2021 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: crashed 98.66% in 2022, then skyrocketed 2950.48% in 2023.
  • Pfizer's Cash & Current Investments stood at $31.1 billion in 2021, then plummeted by 98.66% to $416.0 million in 2022, then surged by 2950.48% to $12.7 billion in 2023, then soared by 61.36% to $20.5 billion in 2024, then decreased by 26.83% to $15.0 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Cash & Current Investments are $15.0 billion (Q3 2025), $1.6 billion (Q2 2025), and $1.4 billion (Q1 2025).